60 related articles for article (PubMed ID: 18722104)
1. Monitoring of hormonal drug effect in a single breast cancer cell using an estrogen responsive GFP reporter vector delivered by a nanoneedle.
Han SW; Nakamura C; Imai Y; Nakamura N; Miyake J
Biosens Bioelectron; 2009 Jan; 24(5):1219-22. PubMed ID: 18722104
[TBL] [Abstract][Full Text] [Related]
2. A molecular delivery system by using AFM and nanoneedle.
Han SW; Nakamura C; Obataya I; Nakamura N; Miyake J
Biosens Bioelectron; 2005 Apr; 20(10):2120-5. PubMed ID: 15741084
[TBL] [Abstract][Full Text] [Related]
3. High-efficiency DNA injection into a single human mesenchymal stem cell using a nanoneedle and atomic force microscopy.
Han SW; Nakamura C; Kotobuki N; Obataya I; Ohgushi H; Nagamune T; Miyake J
Nanomedicine; 2008 Sep; 4(3):215-25. PubMed ID: 18501680
[TBL] [Abstract][Full Text] [Related]
4. Development of a stable dual cell-line GFP expression system to study estrogenic endocrine disruptors.
Xu H; Kraus WL; Shuler ML
Biotechnol Bioeng; 2008 Dec; 101(6):1276-87. PubMed ID: 18980187
[TBL] [Abstract][Full Text] [Related]
5. [Gene delivery system based on low molecular weight polyethylenimine and its transfection activity in the skin tissue].
Liu YJ; Li YP; Li J; Jia JF; Liu L
Shi Yan Sheng Wu Xue Bao; 2004 Apr; 37(2):91-5. PubMed ID: 15259980
[TBL] [Abstract][Full Text] [Related]
6. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
7. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro].
Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of a recombinant adeno-associated virus 2 vector in human CD34+ cells and breast cancer cells.
Veldwijk MR; Fruehauf S; Schiedlmeier B; Kleinschmidt JA; Zeller WJ
Cancer Gene Ther; 2000 Apr; 7(4):597-604. PubMed ID: 10811478
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
Wilson VS; Bobseine K; Gray LE
Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
[TBL] [Abstract][Full Text] [Related]
10. Single-cell manipulation and DNA delivery technology using atomic force microscopy and nanoneedle.
Han SW; Nakamura C; Miyake J; Chang SM; Adachi T
J Nanosci Nanotechnol; 2014 Jan; 14(1):57-70. PubMed ID: 24730251
[TBL] [Abstract][Full Text] [Related]
11. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors.
McLeskey SW; Zhang L; El-Ashry D; Trock BJ; Lopez CA; Kharbanda S; Tobias CA; Lorant LA; Hannum RS; Dickson RB; Kern FG
Clin Cancer Res; 1998 Mar; 4(3):697-711. PubMed ID: 9533540
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
[TBL] [Abstract][Full Text] [Related]
14. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
15. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
16. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
17. Characterization of stably transfected fusion protein GFP-estrogen receptor-alpha in MCF-7 human breast cancer cells.
Zhao H; Hart LL; Keller U; Holth LT; Davie JR
J Cell Biochem; 2002; 86(2):365-75. PubMed ID: 12112006
[TBL] [Abstract][Full Text] [Related]
18. GFP-reporter for a high throughput assay to monitor estrogenic compounds.
Beck V; Pfitscher A; Jungbauer A
J Biochem Biophys Methods; 2005 Jul; 64(1):19-37. PubMed ID: 15992933
[TBL] [Abstract][Full Text] [Related]
19. Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction.
Matsumoto M; Yamaguchi Y; Seino Y; Hatakeyama A; Takei H; Niikura H; Ito K; Suzuki T; Sasano H; Yaegashi N; Hayashi S
Endocr Relat Cancer; 2008 Jun; 15(2):451-63. PubMed ID: 18508998
[TBL] [Abstract][Full Text] [Related]
20. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
Sui M; Jiang D; Hinsch C; Fan W
Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
